Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer
The purposes of this study are to determine the safety of pemetrexed and any side effects that might be associated with it, whether pemetrexed can help patients with breast cancer and how much pemetrexed should be given to patients.
Breast Cancer
DRUG: pemetrexed
To assess tumor response.
To evaluate the toxicity profile of two doses of pemetrexed in breast cancer patients.|To assess the following time-to-event efficacy variables: time to response, duration of response, duration of stable disease, time to documented progressive disease, time to treatment failure, progression-free survival, and overall survival.|To identify the relationships, if any, that may exist between various molecular markers and pemetrexed efficacy and toxicity.
The purposes of this study are to determine the safety of pemetrexed and any side effects that might be associated with it, whether pemetrexed can help patients with breast cancer and how much pemetrexed should be given to patients.